Rinascera Therapeutics, Inc.
Form D Filings
Location
Boston, MA
Industry Group
Biotechnology
Related People
Nichola Eliovits
,
Max Dawson
,
Karl Beutner
,
Daniel Yadegar
Entity Type
Corporation
CIK
0002090779
All SEC Filings
View on sec.gov
Date Filed
Security Types
Total Amount Sold
Total Offering
Amount Remaining
First Sale
Signed
Form
SEC Link
10/8/2025
Equity
$2,500,000
$2,500,000
$0
9/12/2025
10/8/2025
D
000209077925000001